Clinical Trial Update: Treatment of Chronic Obstructive Pulmonary Disease by Infusion of Allogenic Mesenchymal Stem Cells [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating infusion of allogeneic mesenchymal stem cells for chronic obstructive pulmonary disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Allogeneic mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Meribank Biotech Co., Ltd. | Conditions: Chronic Obstructive Pulmonary Disease | Phase 2 | Status: RECRUITING